TY - JOUR T1 - Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer JO - Urologic Oncology: Seminars and Original Investigations UR - https://doi.org/10.1016/j.urolonc.2024.12.264 PY - 2025/01/15 AU - Daneshmand S AU - Kamat AM AU - Shore ND AU - Meeks JJ AU - Galsky MD AU - Jacob JM AU - van der Heijden MS AU - Williams SB AU - Powles T AU - Chang SS AU - Catto JWF et al ED - DO - DOI: 10.1016/j.urolonc.2024.12.264 PB - Elsevier BV Y2 - 2025/08/13 ER -